- Home>
- Specialties>
- Oncology and Hematology>
- Editor's Picks
Oncology and Hematology Editor's Picks
SUMMARY AND COMMENT
A New Factor Xa Inhibitor Prepares for Its Close-Up
- October 7, 2009
- Beat J. Meyer, MD
- Cardiology
Otamixaban shows promise in patients with ACS, but do we really need another intravenous anticoagulant?
- Reviewing:
- Sabatine MS et al. Lancet 2009 Sep 5; 374:787
SUMMARY AND COMMENT
Mastectomy Rates Are RisingFree
- October 1, 2009
- Allan S. Brett, MD
- General Medicine
And breast-conserving surgery rates are falling — Can preoperative MRI be responsible? Interview
- Reviewing:
- Katipamula R et al. J Clin Oncol 2009 Sep 1; 27:4082
SUMMARY AND COMMENT
Is Clinical Breast Examination, Added to Mammography, Worthwhile?
- October 1, 2009
- Allan S. Brett, MD
- General Medicine
CBE was associated with 55 additional false-positives for each additional breast cancer detected.
- Reviewing:
- Chiarelli AM et al. J Natl Cancer Inst 2009 Sep 16; 101:1236
SUMMARY AND COMMENT
Polymorphisms in CTLA4 Confer Susceptibility to Nonmelanoma Skin CancersFree
- September 25, 2009
- Craig A. Elmets, MD
- Dermatology
A genetic variant that confers excess risk for autoimmune disease may also protect against nonmelanoma skin cancers.
- Reviewing:
- Welsh MM et al. Cancer Res 2009 Aug 1; 69:6158
SUMMARY AND COMMENT
Warfarin for Stroke Prevention in Patients with Atrial Fibrillation
- September 16, 2009
- Joel M. Gore, MD
- Cardiology
Results of a large observational study provide current data for accurate risk-benefit estimation. CME
- Reviewing:
- Singer DE et al. Ann Intern Med 2009 Sep 1; 151:297
SUMMARY AND COMMENT
Overdiagnosis in PSA Screening
- September 24, 2009
- Allan S. Brett, MD
- General Medicine
An analysis suggests that many men have been treated unnecessarily because of PSA screening.
- Reviewing:
- Welch HG and Albertsen PC. J Natl Cancer Inst 2009 Aug 31
SUMMARY AND COMMENT
An Alternative to Warfarin in Patients with Atrial Fibrillation?
- September 1, 2009
- Harlan M. Krumholz, MD, SM
- Cardiology
Compared with warfarin, low-dose dabigatran performed better with regard to safety but not efficacy, and high-dose dabigatran performed better with regard to efficacy but not safety.
- Reviewing:
- Connolly SJ et al. for the RE-LY Steering Committee and Investigators. N Engl J Med 2009 Aug 30
SUMMARY AND COMMENT
Refining Antiplatelet Treatment in Patients with Acute Coronary Syndromes
- September 2, 2009
- Beat J. Meyer, MD
- Cardiology
In a randomized trial, oral ticagrelor outperformed clopidogrel.
- Reviewing:
- Wallentin L et al. for the PLATO Investigators. N Engl J Med 2009 Sep 10; 361:1045
SUMMARY AND COMMENT
Photodynamic Therapy and the Immune System
- August 14, 2009
- Craig A. Elmets, MD
- Dermatology
PDT apparently increases antitumor immunity in addition to directly destroying lesions of basal cell carcinoma.
- Reviewing:
- Kabingu E et al. Clin Cancer Res 2009 Jul 1; 15:4460
SUMMARY AND COMMENT
Ovarian Status and Risk for Lung Cancer
- September 3, 2009
- Andrew M. Kaunitz, MD
- Women's Health
Further evidence that functional ovaries protect against lung cancer
- Reviewing:
- Koushik A et al. Int J Cancer 2009 May 11
Read more Oncology and Hematology Editor's Picks articles >>
